Effect of honokiol on erythrocytes

Toxicology in Vitro

Volumn 27, Issue 6, 2013, Pages 1737-1745

  Zbidah, Mohanad ^a   Lupescu, Adrian ^a   Herrmann, Tabea ^a   Yang, Wenting ^a   Foller, Michael ^a   Jilani, Kashif ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Calcium; Cell volume; Eryptosis; Honokiol; Phosphatidylserine

Indexed keywords

ANTIBODY; CALCIUM ION; CERAMIDE; HEMOGLOBIN; HONOKIOL; LIPOCORTIN 5; PHOSPHATIDYLSERINE;

APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CELL MEMBRANE; CELL SHRINKAGE; CELL VOLUME; CONTROLLED STUDY; CYTOSOL; DRUG ACTIVITY; DRUG EFFECT; ERYPTOSIS; ERYTHROCYTE; EXTRACELLULAR CALCIUM; FLUORESCENT ANTIBODY TECHNIQUE; HEMOLYSIS; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN TRANSPORT;

CALCIUM; CELL VOLUME; ERYPTOSIS; HONOKIOL; PHOSPHATIDYLSERINE;

BIPHENYL COMPOUNDS; CALCIUM; CELL DEATH; CELL SIZE; CELLS, CULTURED; ERYTHROCYTES; HEMOLYSIS; HUMANS; LIGNANS; PHOSPHATIDYLSERINES;

MAGNOLIA OFFICINALIS;

EID: 84878771741     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.05.003     Document Type: Article

References (109)

1. Abed M., Towhid S.T., Mia S., Pakladok T., Alesutan I., Borst O., Gawaz M., Gulbins E., Lang F. Sphingomyelinase-induced adhesion of eryptotic erythrocytes to endothelial cells. Am. J. Physiol. Cell Physiol. 2012, 303:C991-C999.
2. Abed M., Towhid S.T., Shaik N., Lang F. Stimulation of suicidal death of erythrocytes by rifampicin. Toxicology 2012, 302:123-128.
3. Andrews D.A., Low P.S. Role of red blood cells in thrombosis. Curr. Opin. Hematol. 1999, 6:76-82.
4. Arora S., Bhardwaj A., Srivastava S.K., Singh S., McClellan S., Wang B., Singh A.P. Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. PLoS One 2011, 6:e21573.
5. Arora S., Singh S., Piazza G.A., Contreras C.M., Panyam J., Singh A.P. Honokiol: a novel natural agent for cancer prevention and therapy. Curr. Mol. Med. 2012, 12:1244-1252.
6. Berg C.P., Engels I.H., Rothbart A., Lauber K., Renz A., Schlosser S.F., Schulze-Osthoff K., Wesselborg S. Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death. Differ. 2001, 8:1197-1206.
7. Bhavsar S.K., Bobbala D., Xuan N.T., Foller M., Lang F. Stimulation of suicidal erythrocyte death by alpha-lipoic acid. Cell. Physiol. Biochem. 2010, 26:859-868.
8. Bhavsar S.K., Gu S., Bobbala D., Lang F. Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell. Physiol. Biochem. 2011, 27:547-556.
9. Birka C., Lang P.A., Kempe D.S., Hoefling L., Tanneur V., Duranton C., Nammi S., Henke G., Myssina S., Krikov M., Huber S.M., Wieder T., Lang F. Enhanced susceptibility to erythrocyte "apoptosis" following phosphate depletion. Pflugers Arch. 2004, 448:471-477.
10. Bobbala D., Alesutan I., Foller M., Huber S.M., Lang F. Effect of anandamide in plasmodium Berghei-infected mice. Cell. Physiol. Biochem. 2010, 26:355-362.
11. Bookchin R.M., Ortiz O.E., Lew V.L. Activation of calcium-dependent potassium channels in deoxygenated sickled red cells. Prog. Clin. Biol. Res. 1987, 240:193-200.
12. Borst O., Abed M., Alesutan I., Towhid S.T., Qadri S.M., Foller M., Gawaz M., Lang F. Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX. Am. J. Physiol. Cell Physiol. 2012, 302:C644-C651.
13. Bottger E., Multhoff G., Kun J.F., Esen M. Plasmodium falciparum-infected erythrocytes induce granzyme B by NK cells through expression of host-Hsp70. PLoS One 2012, 7:e33774.
14. Brand V.B., Sandu C.D., Duranton C., Tanneur V., Lang K.S., Huber S.M., Lang F. Dependence of Plasmodium falciparum in vitro growth on the cation permeability of the human host erythrocyte. Cell. Physiol. Biochem. 2003, 13:347-356.
15. Brugnara C., de Franceschi L., Alper S.L. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J. Clin. Invest. 1993, 92:520-526.
16. Calderon-Salinas J.V., Munoz-Reyes E.G., Guerrero-Romero J.F., Rodriguez-Moran M., Bracho-Riquelme R.L., Carrera-Gracia M.A., Quintanar-Escorza M.A. Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease. Mol. Cell. Biochem. 2011, 357:171-179.
17. Chen F., Wang T., Wu Y.F., Gu Y., Xu X.L., Zheng S., Hu X. Honokiol: a potent chemotherapy candidate for human colorectal carcinoma. World J. Gastroenterol. 2004, 10:3459-3463.
18. Chen X.R., Lu R., Dan H.X., Liao G., Zhou M., Li X.Y., Ji N. Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells. Int. J. Oral Sci. 2011, 3:34-42.
19. Cheng N., Xia T., Han Y., He Q.J., Zhao R., Ma J.R. Synergistic antitumor effects of liposomal honokiol combined with cisplatin in colon cancer models. Oncol. Lett. 2011, 2:957-962.
20. Chilampalli C., Guillermo R., Kaushik R.S., Young A., Chandrasekher G., Fahmy H., Dwivedi C. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells. Exp. Biol. Med. (Maywood) 2011, 236:1351-1359.
21. Chung S.M., Bae O.N., Lim K.M., Noh J.Y., Lee M.Y., Jung Y.S., Chung J.H. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler. Thromb. Vas. Biol 2007, 27:414-421.
22. Closse C., Dachary-Prigent J., Boisseau M.R. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Brit. J. Haematol. 1999, 107:300-302.
23. Felder K.M., Hoelzle K., Ritzmann M., Kilchling T., Schiele D., Heinritzi K., Groebel K., Hoelzle L.E. Hemotrophic mycoplasmas induce programmed cell death in red blood cells. Cell. Physiol. Biochem. 2011, 27:557-564.
24. Firat U., Kaya S., Cim A., Buyukbayram H., Gokalp O., Dal M.S., Tamer M.N. Increased caspase-3 immunoreactivity of erythrocytes in STZ diabetic rats. Exp. Diabetes Res. 2012, 2012:316384.
25. Foller M., Feil S., Ghoreschi K., Koka S., Gerling A., Thunemann M., Hofmann F., Schuler B., Vogel J., Pichler B., Kasinathan R.S., Nicolay J.P., Huber S.M., Lang F., Feil R. Anemia and splenomegaly in cGKI-deficient mice. Proc. Natl. Acad. Sci. USA 2008, 105:6771-6776.
26. Foller M., Huber S.M., Lang F. Erythrocyte programmed cell death. IUBMB Life 2008, 60:661-668.
27. Foller M., Kasinathan R.S., Koka S., Lang C., Shumilina E., Birnbaumer L., Lang F., Huber S.M. TRPC6 contributes to the Ca(2+) leak of human erythrocytes. Cell. Physiol. Biochem. 2008, 21:183-192.
28. Foller M., Bobbala D., Koka S., Huber S.M., Gulbins E., Lang F. Suicide for survival-death of infected erythrocytes as a host mechanism to survive malaria. Cell. Physiol. Biochem. 2009, 24:133-140.
29. Foller M., Mahmud H., Gu S., Wang K., Floride E., Kucherenko Y., Luik S., Laufer S., Lang F. Participation of leukotriene C(4) in the regulation of suicidal erythrocyte death. J. Physiol. Pharmacol. 2009, 60:135-143.
30. Foller M., Sopjani M., Koka S., Gu S., Mahmud H., Wang K., Floride E., Schleicher E., Schulz E., Munzel T., Lang F. Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J. 2009, 23:1072-1080.
31. Fried L.E., Arbiser J.L. Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid. Redox. Signal 2009, 11:1139-1148.
32. Gallagher P.G., Chang S.H., Rettig M.P., Neely J.E., Hillery C.A., Smith B.D., Low P.S. Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 2003, 101:4625-4627.
33. Ganesan S., Chaurasiya N.D., Sahu R., Walker L.A., Tekwani B.L. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway. Toxicology 2012, 294:54-60.
34. Gao M., Cheung K.L., Lau I.P., Yu W.S., Fung K.P., Yu B., Loo J.F., Kong S.K. Polyphyllin D induces apoptosis in human erythrocytes through Ca(2)(+) rise and membrane permeabilization. Arch. Toxicol. 2012, 86:741-752.
35. Gatidis S., Zelenak C., Fajol A., Lang E., Jilani K., Michael D., Qadri S.M., Lang F. P38 MAPK activation and function following osmotic shock of erythrocytes. Cell. Physiol. Biochem. 2011, 28:1279-1286.
36. Ghashghaeinia M., Toulany M., Saki M., Bobbala D., Fehrenbacher B., Rupec R., Rodemann H.P., Ghoreschi K., Rocken M., Schaller M., Lang F., Wieder T. The NFkB pathway inhibitors Bay 11-7082 and parthenolide induce programmed cell death in anucleated erythrocytes. Cell. Physiol. Biochem. 2011, 27:45-54.
37. Ghashghaeinia M., Cluitmans J.C., Akel A., Dreischer P., Toulany M., Koberle M., Skabytska Y., Saki M., Biedermann T., Duszenko M., Lang F., Wieder T., Bosman G.J. The impact of erythrocyte age on eryptosis. Brit. J. Haematol. 2012, 157:606-614.
38. He Z., Subramaniam D., Ramalingam S., Dhar A., Postier R.G., Umar S., Zhang Y., Anant S. Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301:G929-G937.
39. Hoi C.P., Ho Y.P., Baum L., Chow A.H. Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells. Phytother. Res. 2010, 24:1538-1542.
40. Ishikawa C., Arbiser J.L., Mori N. Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia. Biochim. Biophys. Acta. 2012, 1820:879-887.
41. Jeong J.J., Lee J.H., Chang K.C., Kim H.J. Honokiol exerts an anticancer effect in T98G human glioblastoma cells through the induction of apoptosis and the regulation of adhesion molecules. Int. J. Oncol. 2012, 10.3892/ijo.2012.1582.
42. Jiang Q.Q., Fan L.Y., Yang G.L., Guo W.H., Hou W.L., Chen L.J., Wei Y.Q. Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model. BMC Cancer 2008, 8:242.
43. Jilani K., Lupescu A., Zbidah M., Abed M., Shaik N., Lang F. Enhanced apoptotic death of erythrocytes induced by the mycotoxin ochratoxin a. Kidney Blood Press Res. 2012, 36:107-118.
44. Jilani K., Lupescu A., Zbidah M., Shaik N., Lang F. Withaferin A-stimulated Ca(2+) entry, ceramide formation and suicidal death of erythrocytes. Toxicol. In Vitro 2013, 27:52-58.
45. Kempe D.S., Lang P.A., Duranton C., Akel A., Lang K.S., Huber S.M., Wieder T., Lang F. Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J. 2006, 20:368-370.
46. Kempe D.S., Akel A., Lang P.A., Hermle T., Biswas R., Muresanu J., Friedrich B., Dreischer P., Wolz C., Schumacher U., Peschel A., Gotz F., Doring G., Wieder T., Gulbins E., Lang F. Suicidal erythrocyte death in sepsis. J. Mol. Med. 2007, 85:269-277.
47. Klarl B.A., Lang P.A., Kempe D.S., Niemoeller O.M., Akel A., Sobiesiak M., Eisele K., Podolski M., Huber S.M., Wieder T., Lang F. Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion. Am. J. Physiol. Cell Physiol. 2006, 290:C244-C253.
48. Koka S., Bobbala D., Lang C., Boini K.M., Huber S.M., Lang F. Influence of paclitaxel on parasitemia and survival of plasmodium berghei infected mice. Cell. Physiol. Biochem. 2009, 23:191-198.
49. Kucherenko Y.V., Lang F. Inhibitory effect of furosemide on non-selective voltage-independent cation channels in human erythrocytes. Cell. Physiol. Biochem. 2012, 30:863-875.
50. Kucherenko Y., Zelenak C., Eberhard M., Qadri S.M., Lang F. Effect of casein kinase 1alpha activator pyrvinium pamoate on erythrocyte ion channels. Cell. Physiol. Biochem. 2012, 30:407-417.
51. Lang F., Qadri S.M. Mechanisms and significance of eryptosis, the suicidal death of erythrocytes. Blood Purif. 2012, 33:125-130.
52. + channels in human erythrocyte apoptosis. Am. J. Physiol. Cell Physiol. 2003, 285:C1553-C1560.
53. Lang P.A., Beringer O., Nicolay J.P., Amon O., Kempe D.S., Hermle T., Attanasio P., Akel A., Schafer R., Friedrich B., Risler T., Baur M., Olbricht C.J., Zimmerhackl L.B., Zipfel P.F., Wieder T., Lang F. Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J. Mol. Med. 2006, 84:378-388.
54. Lang P.A., Schenck M., Nicolay J.P., Becker J.U., Kempe D.S., Lupescu A., Koka S., Eisele K., Klarl B.A., Rubben H., Schmid K.W., Mann K., Hildenbrand S., Hefter H., Huber S.M., Wieder T., Erhardt A., Haussinger D., Gulbins E., Lang F. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat. Med. 2007, 13:164-170.
55. Lang F., Gulbins E., Lerche H., Huber S.M., Kempe D.S., F"ller M. Eryptosis, a window to systemic disease. Cell Physiol. Biochem. 2008, 22:373-380.
56. Lang P.A., Kasinathan R.S., Brand V.B., Duranton C., Lang C., Koka S., Shumilina E., Kempe D.S., Tanneur V., Akel A., Lang K.S., Foller M., Kun J.F., Kremsner P.G., Wesselborg S., Laufer S., Clemen C.S., Herr C., Noegel A.A., Wieder T., Gulbins E., Lang F., Huber S.M. Accelerated clearance of Plasmodium-infected erythrocytes in sickle cell trait and annexin-A7 deficiency. Cell Physiol. Biochem. 2009, 24:415-428.
57. Lang F., Gulbins E., Lang P.A., Zappulla D., Foller M. Ceramide in suicidal death of erythrocytes. Cell Physiol. Biochem. 2010, 26:21-28.
58. Lang E., Jilani K., Zelenak C., Pasham V., Bobbala D., Qadri S.M., Lang F. Stimulation of suicidal erythrocyte death by benzethonium. Cell Physiol. Biochem. 2011, 28:347-354.
59. Lang E., Qadri S.M., Jilani K., Zelenak C., Lupescu A., Schleicher E., Lang F. Carbon monoxide-sensitive apoptotic death of erythrocytes. Basic Clin. Pharmacol. Toxicol. 2012, 111:348-355.
60. Lang E., Qadri S.M., Lang F. Killing me softly - suicidal erythrocyte death. Int. J. Biochem. Cell Biol. 2012, 44:1236-1243.
61. Lau, I.P., Chen, H., Wang, J., Ong, H.C., Leung, K.C., Ho, H.P., Kong, S.K., 2011. In vitro effect of CTAB- and PEG-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes. Nanotoxicology.
62. Lee Y.J., Lee Y.M., Lee C.K., Jung J.K., Han S.B., Hong J.T. Therapeutic applications of compounds in the Magnolia family. Pharmacol. Ther. 2011, 130:157-176.
63. Lee J.D., Lee J.Y., Baek B.J., Lee B.D., Koh Y.W., Lee W.S., Lee Y.J., Kwon B.M. The inhibitory effect of honokiol, a natural plant product, on vestibular schwannoma cells. Laryngoscope 2012, 122:162-166.
64. Leeman-Neill R.J., Cai Q., Joyce S.C., Thomas S.M., Bhola N.E., Neill D.B., Arbiser J.L., Grandis J.R. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors. Clin. Cancer Res. 2010, 16:2571-2579.
65. Li Y., Huang W., Huang S., Du J., Huang C. Screening of anti-cancer agent using zebrafish: comparison with the MTT assay. Biochem. Biophys. Res. Commun. 2012, 422:85-90.
66. Lin J.W., Chen J.T., Hong C.Y., Lin Y.L., Wang K.T., Yao C.J., Lai G.M., Chen R.M. Honokiol traverses the blood-brain barrier and induces apoptosis of neuroblastoma cells via an intrinsic bax-mitochondrion-cytochrome c-caspase protease pathway. Neuro Oncol. 2012, 14:302-314.
67. Liu S.H., Shen C.C., Yi Y.C., Tsai J.J., Wang C.C., Chueh J.T., Lin K.L., Lee T.C., Pan H.C., Sheu M.L. Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals. Br. J. Pharmacol. 2010, 160:1963-1972.
68. Liu X., Han Y., Peng K., Liu Y., Li J., Liu H. Effect of traditional Chinese medicinal herbs on Candida spp. from patients with HIV/AIDS. Adv. Dent. Res. 2011, 23:56-60.
69. Liu S.H., Wang K.B., Lan K.H., Lee W.J., Pan H.C., Wu S.M., Peng Y.C., Chen Y.C., Shen C.C., Cheng H.C., Liao K.K., Sheu M.L. Calpain/SHP-1 interaction by honokiol dampening peritoneal dissemination of gastric cancer in nu/nu mice. PLoS One 2012, 7:e43711.
70. Lupescu, A., Jilani, K., Zbidah, M., Lang, E., Lang, F., 2012a. Enhanced Ca(2+) entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin. J. Nat. Prod.
71. Lupescu A., Jilani K., Zbidah M., Lang F. Induction of apoptotic erythrocyte death by rotenone. Toxicology 2012, 300:132-137.
72. Lupescu A., Jilani K., Zelenak C., Zbidah M., Qadri S.M., Lang F. Hexavalent chromium-induced erythrocyte membrane phospholipid asymmetry. Biometals 2012, 25:309-318.
73. Lupescu A., Shaik N., Jilani K., Zelenak C., Lang E., Pasham V., Zbidah M., Plate A., Bitzer M., Foller M., Qadri S.M., Lang F. Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro study. Cell Physiol. Biochem. 2012, 30:876-888.
74. Maellaro, E., Leoncini, S., Moretti, D., Del Bello, B., Tanganelli, I., De Felice, C., Ciccoli, L., 2011. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol.
75. Mannal P.W., Schneider J., Tangada A., McDonald D., McFadden D.W. Honokiol produces anti-neoplastic effects on melanoma cells in vitro. J. Surg. Oncol. 2011, 104:260-264.
76. Marin G.H., Mansilla E. Apoptosis induced by Magnolia Grandi fl ora extract in chlorambucil-resistant B-chronic lymphocytic leukemia cells. J. Cancer Res. Ther. 2010, 6:463-465.
77. Myssina S., Huber S.M., Birka C., Lang P.A., Lang K.S., Friedrich B., Risler T., Wieder T., Lang F. Inhibition of erythrocyte cation channels by erythropoietin. J. Am. Soc. Nephrol. 2003, 14:2750-2757.
78. Nicolay J.P., Schneider J., Niemoeller O.M., Artunc F., Portero-Otin M., Haik G., Thornalley P.J., Schleicher E., Wieder T., Lang F. Stimulation of suicidal erythrocyte death by methylglyoxal. Cell Physiol. Biochem. 2006, 18:223-232.
79. Pandolfi A., Di Pietro N., Sirolli V., Giardinelli A., Di Silvestre S., Amoroso L., Di Tomo P., Capani F., Consoli A., Bonomini M. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J. Cell Physiol. 2007, 213:699-709.
80. Polak-Jonkisz D., Purzyc L. Ca influx versus efflux during eryptosis in uremic erythrocytes. Blood Purif. 2012, 34:209-210.
81. Ponnurangam S., Mammen J.M., Ramalingam S., He Z., Zhang Y., Umar S., Subramaniam D., Anant S. Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells. Mol. Cancer Ther. 2012, 11:963-972.
82. Qadri S.M., Bauer J., Zelenak C., Mahmud H., Kucherenko Y., Lee S.H., Ferlinz K., Lang F. Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death. Cell Physiol. Biochem. 2011, 28:339-346.
83. Qadri S.M., Kucherenko Y., Lang F. Beauvericin induced erythrocyte cell membrane scrambling. Toxicology 2011, 283:24-31.
84. 2+-permeable cation channels triggering erythrocyte cell membrane scrambling. Cell Physiol. Biochem. 2011, 28:857-864.
85. Qadri S.M., Mahmud H., Lang E., Gu S., Bobbala D., Zelenak C., Jilani K., Siegfried A., Foller M., Lang F. Enhanced suicidal erythrocyte death in mice carrying a loss-of-function mutation of the adenomatous polyposis coli gene. J. Cell Mol. Med. 2012, 16:1085-1093.
86. Qian E.W., Ge D.T., Kong S.K. Salidroside protects human erythrocytes against hydrogen peroxide-induced apoptosis. J. Nat. Prod. 2012, 75:531-537.
87. Rajendran P., Li F., Shanmugam M.K., Vali S., Abbasi T., Kapoor S., Ahn K.S., Kumar A.P., Sethi G. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1. J. Cell Physiol. 2012, 227:2184-2195.
88. Shaik N., Lupescu A., Lang F. Sunitinib-sensitive suicidal erythrocyte death. Cell Physiol. Biochem. 2012, 30:512-522.
89. Shaik N., Zbidah M., Lang F. Inhibition of Ca(2+) entry and suicidal erythrocyte death by naringin. Cell Physiol. Biochem. 2012, 30:678-686.
90. Shen J.L., Man K.M., Huang P.H., Chen W.C., Chen D.C., Cheng Y.W., Liu P.L., Chou M.C., Chen Y.H. Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders. Molecules 2010, 15:6452-6465.
91. Sheu M.L., Chiang C.K., Tsai K.S., Ho F.M., Weng T.I., Wu H.Y., Liu S.H. Inhibition of NADPH oxidase-related oxidative stress-triggered signaling by honokiol suppresses high glucose-induced human endothelial cell apoptosis. Free Radic. Biol. Med. 2008, 44:2043-2050.
92. Siraskar B., Ballal A., Bobbala D., Foller M., Lang F. Effect of amphotericin B on parasitemia and survival of plasmodium berghei-infected mice. Cell Physiol. Biochem. 2010, 26:347-354.
93. Steinmann P., Walters D.K., Arlt M.J., Banke I.J., Ziegler U., Langsam B., Arbiser J., Muff R., Born W., Fuchs B. Antimetastatic activity of honokiol in osteosarcoma. Cancer 2012, 118:2117-2127.
94. Tang X., Yao K., Zhang L., Yang Y., Yao H. Honokiol inhibits H(2)O(2)-induced apoptosis in human lens epithelial cells via inhibition of the mitogen-activated protein kinase and Akt pathways. Eur. J. Pharmacol. 2011, 650:72-78.
95. Vota, D.M., Maltaneri, R.E., Wenker, S.D., Nesse, A.B., Vittori, D.C., 2012. Differential Erythropoietin Action upon Cells Induced to Eryptosis by Different Agents. Cell Biochem. Biophys.
96. Wang Y., Yang Z., Zhao X. Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells. Toxicol. Mech. Meth. 2010, 20:234-241.
97. Wang X., Duan X., Yang G., Zhang X., Deng L., Zheng H., Deng C., Wen J., Wang N., Peng C., Zhao X., Wei Y., Chen L. Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model. PLoS One 2011, 6:e18490.
98. Weiss E., Cytlak U.M., Rees D.C., Osei A., Gibson J.S. Deoxygenation-induced and Ca(2+) dependent phosphatidylserine externalisation in red blood cells from normal individuals and sickle cell patients. Cell Calcium 2012, 51:51-56.
99. Weng T.I., Wu H.Y., Chen B.L., Liu S.H. Honokiol attenuates the severity of acute pancreatitis and associated lung injury via acceleration of acinar cell apoptosis. Shock 2012, 37:478-484.
100. Wood B.L., Gibson D.F., Tait J.F. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996, 88:1873-1880.
101. Xu H.L., Tang W., Du G.H., Kokudo N. Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of Magnolia officinalis. Drug Discov. Ther. 2011, 5:202-210.
102. Yu C., Zhang Q., Zhang H.Y., Zhang X., Huo X., Cheng E., Wang D.H., Arbiser J.L., Spechler S.J., Souza R.F. Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 303:G561-G569.
103. 2 increases?. J. Cardiometab. Syndr. 2008, 3:30-34.
104. Zbidah, M., Lupescu, A., Jilani, K., Lang, F., 2012a. Stimulation of Suicidal Erythrocyte Death by Fumagillin. Basic Clin. Pharmacol. Toxicol.
105. Zbidah, M., Lupescu, A., Shaik, N., Lang, F., 2012b. Gossypol-induced suicidal erythrocyte death. Toxicology.
106. Zelenak C., Foller M., Velic A., Krug K., Qadri S.M., Viollet B., Lang F., Macek B. Proteome analysis of erythrocytes lacking AMP-activated protein kinase reveals a role of PAK2 kinase in eryptosis. J. Proteome Res. 2011, 10:1690-1697.
107. Zelenak C., Eberhard M., Jilani K., Qadri S.M., Macek B., Lang F. Protein kinase CK1alpha regulates erythrocyte survival. Cell Physiol. Biochem. 2012, 29:171-180.
108. Zelenak C., Pasham V., Jilani K., Tripodi P.M., Rosaclerio L., Pathare G., Lupescu A., Faggio C., Qadri S.M., Lang F. Tanshinone IIA stimulates erythrocyte phosphatidylserine exposure. Cell Physiol. Biochem. 2012, 30:282-294.
109. Zwaal R.F., Comfurius P., Bevers E.M. Surface exposure of phosphatidylserine in pathological cells. Cell Mol. Life Sci. 2005, 62:971-988.